Independent valuation service for OTC derivatives launched

JP Morgan Investor Services (JPMIS), part of JP Morgan Chase, has launched an independent valuation service for over-the-counter derivatives.

JPMIS said it is the first global custodian to offer a comprehensive OTC valuation service as part of a fund accounting product, adding that the move is in response to fund managers and institutional investors moving increasingly into alternative investments and derivatives.

“We administer a growing number of OTC positions because institutional investors are adopting hedge-fund orientated strategies,” said Chris Jones, head of European fund accounting product management at JPMIS. “We are in the business of providing independent and transparent investment valuations, so this is a natural evolution,” he added.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here